Alert

Recommended Alerts

Sign Up For Alerts

CMS Issues Final Rule Redefining Medicare Part D “Negotiated Price” As Pharmacy’s Lowest Possible Reimbursement

On April 29, 2022, the Centers for Medicare & Medicaid Services (“CMS”) issued a final rule revising the way Medicare determines the “negotiated price” (i.e., the price upon which beneficiary cost-sharing is based at the pharmacy counter) under Medicare Part D.

Read More

FDA Draft Guidance Would Restrict Marketing of Research Use Only and Investigational Use Only In Vitro Diagnostic Products

Practices: Life Sciences Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

Cookie Settings